Taiwan FDA registration c7d3c0019af193f91ced098be8ab6803
"Parkson" intracoronary stent system
TW: “百盛”冠狀動脈內支架系統
Taiwan·Risk Class 3·BIOSENSORS INTERVENTIONAL TECHNOLOGIES PTE LTD.·Registered Jun 15, 2010 – Jun 15, 2020CancelledRegistration details
- Analysis ID
- c7d3c0019af193f91ced098be8ab6803
- Customs Code
- DHA00602112701
Company information
- Manufacturer
- BIOSENSORS INTERVENTIONAL TECHNOLOGIES PTE LTD.
- Manufacturer Country
- Singapore
- Authorized Representative
- IDS MEDICAL SYSTEMS (HONG KONG) COMPANY LIMITED, TAIWAN BRANCH (HONG KONG)
Product details
- Intended Use
- For details, it is Chinese approved copy of the imitation order
- Product Type (Level 1)
- E Cardiovascular Medicine Science
- Product Type (Level 2)
- E.0001 Cardiovascular stents
- Import Information
- import
Dates and status
- Registration Date
- Jun 15, 2010
- Expiry Date
- Jun 15, 2020
- Cancellation Date
- Jun 07, 2022
Cancellation information
- Status
- Logged out
- Reason
- 許可證已逾有效期
About this record
Access comprehensive regulatory information for "Parkson" intracoronary stent system in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 3 medical device is registered under number c7d3c0019af193f91ced098be8ab6803 and manufactured by BIOSENSORS INTERVENTIONAL TECHNOLOGIES PTE LTD.. The authorized representative in Taiwan is IDS MEDICAL SYSTEMS (HONG KONG) COMPANY LIMITED, TAIWAN BRANCH (HONG KONG).
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices